门控与非门控增强CT上野生型转甲状腺素蛋白淀粉样心肌病的影像特征
回顾性分析43例野生型ATTR-CM与43例匹配对照,在常规非门控增强CT门静脉期半定量评估心肌低强化。ATTR-CM组心肌低强化评分显著高于对照组,且与ECV和整体纵向应变相关,低强化主要位于基底段。门控冠状动脉CTA对延迟强化节段的检出敏感度高于非门控门静脉期CT。
要点
- 常规非门控增强CT上门静脉期心肌低强化主要位于基底段,ATTR-CM组评分显著高于对照组。
- 心肌低强化与延迟强化一致性良好(kappa=0.43),90.4%的低强化节段可见延迟强化。
- 门控冠状动脉CTA对延迟强化节段的检出敏感度高于非门控门静脉期CT(87.1% vs 69.2%,p<0.01)。
核心结论
- 野生型ATTR-CM在常规非门控增强CT上表现为以基底段为主的心肌低强化倾向,提示与心肌微循环功能障碍相关。
研究设计与样本
- 回顾性分析43例连续诊断为野生型ATTR-CM的患者,并与43例按年龄、性别、身高和体重匹配的对照进行比较;在常规非门控增强CT门静脉期进行心肌低强化半定量评估并计算心肌低强化评分(MHES),同时评估评分与心肌细胞外容积分数(ECV)等临床参数的相关性。
关键影像表现/征象
- 常规非门控增强CT门静脉期可见心肌低强化,主要位于基底段。
- 心肌低强化与延迟强化一致性良好(kappa=0.43),90.4%的低强化节段可见延迟强化。
诊断标准与关键数值
- 心肌低强化评分(MHES)在ATTR-CM组显著高于对照组(p<0.01)。
- MHES在高ECV ATTR-CM亚组(>55%)显著高于低ECV ATTR-CM亚组(≤55%)和对照组。
- 门控冠状动脉CTA对延迟强化节段的检出敏感度为87.1%,非门控门静脉期CT为69.2%(p<0.01)。
临床应用与阅片要点
- 在缺乏延迟碘增强成像的条件下,常规非门控增强CT门静脉期发现基底段心肌低强化可为ATTR-CM提供诊断线索。
- 心肌低强化评分与ECV和整体纵向应变相关,提示其可能反映心肌微循环功能障碍。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: Wild-type transthyretin amyloid cardiomyopathy (ATTR-CM) could be common, but its diagnosis is often overlooked. If the imaging features of ATTR-CM can be identified using conventional computed tomography (CT), which is commonly employed in clinical practice, its diagnostic value would be great. This study aimed to assess the imaging features of the condition in conventional non-gated contrast-enhanced CT.
METHODS: We retrospectively analyzed 43 consecutive patients diagnosed with wild-type ATTR-CM and performed a semi-quantitative evaluation of myocardial hypo-enhancement in the portal venous phase of conventional contrast-enhanced CT. A myocardial hypo-enhancement score (MHES) was calculated and compared between patients with ATTR-CM and 43 age-, sex-, height-, and weight-matched controls. Correlations between the score and clinical parameters such as the myocardial extracellular volume fraction (ECV) were also assessed.
RESULTS: The MHES was significantly higher in the ATTR-CM group than in the control group (p < 0.01). It was also significantly higher in the high-ECV ATTR-CM subgroup (> 55%) than in the low-ECV ATTR-CM (≤ 55%) subgroup and the control group. There was good agreement between myocardial hypo-enhancement and late enhancement (kappa = 0.43), with 90.4% of the hypo-enhanced segments showing late enhancement. The detection sensitivity of late enhancement segments was higher in gated coronary CT angiography than in non-gated portal venous phase CT (69.2% vs 87.1%, p < 0.01).
CONCLUSION: Wild-type ATTR-CM exhibited a tendency for myocardial hypo-enhancement, predominantly in the basal segments on conventional non-gated contrast-enhanced CT, suggesting an association with myocardial microcirculatory dysfunction.
KEY POINTS: Question Can myocardial hypo-enhancement in non-gated contrast-enhanced CT help diagnose wild-type ATTR-CM, particularly in settings where late iodine enhancement imaging is unavailable? Findings Hypo-enhancement, predominantly in basal segments, was higher in ATTR-CM patients and correlated with ECV and global longitudinal strain, suggesting microcirculatory dysfunction. Clinical relevance Identifying myocardial hypo-enhancement in basal segments on conventional non-gated contrast-enhanced CT may provide a valuable diagnostic clue for ATTR-CM, particularly in facilities lacking LIE imaging, allowing for earlier recognition and potential clinical intervention.
引用
- Yamaguchi S, Oda S, Kidoh M, et al. Imaging features of wild-type transthyretin amyloid cardiomyopathy in gated and non-gated contrast-enhanced CT. Eur Radiol. 2025. PMID: 40307527. doi:10.1007/s00330-025-11631-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。